The Animal Imaging Core provides services for molecular imaging of rodent models of human cancer.The Core provides investigators with non-invasive, high-resolution quantitative imaging-based capabilitiesfor metabolic and genetic characterization of tumors and their microenvironment, including in vivo traffickingof tumor cells. This is accomplished by monitoring of 'directly-targeting' probes and of the expression ofsingle and multi-modality reporter genes using optical (bioluminescence and fluorescence), radionuclide(PET, SPECT, and autoradiography), MRI/MRS, CT, and US imaging. These imaging techniques are wellestablishedat MSKCC for small-animal imaging studies. They are quantitative and non-invasive and thusreadily adaptable to longitudinal studies. The Animal Imaging Core also provides investigators with accessto critical ancillary equipment and services such as a Fuji Film BAS-180011 phosphor-plate digitalautoradiography system, a digital-camera-equipped Olympus B 201 fluorescence microscope withmotorized stage, and a Microm HM500M cryostatic microtome.As part of a major expansion and modernization of MSKCC's infrastructure (Phase 1), part of the ImagingCore has recently re-located to the C4 level within the Vivarium of the new Zuckerman Research Center.This area provides enhanced biosecurity and functionality and houses our R4 and Focus 120 microPETdedicated high-resolution small-animal (rodent) PETs, new MS 200 optical imaging system, microCAT IIdedicated small-animal (rodent) CT, and X-SPECT dedicated small-animal SPECT-CT. The existing MS100 optical imaging system and recently installed Vevo 770 ultrasound system have been re-located torefurbished space on the 12th floor of the Rockefeller Research Laboratory providing improved access tothe primary users of these two systems. The Imaging Core's 4.7-T 40-cm bore and 7.0-T 31-cm BruckerNMR imaging and spectroscopy systems are currently located in the MRI Building. In Phase 2 of MSKCC'scapital expansion and modernization, all of the foregoing instrumentation of the Imaging Core will beconsolidated in spacious, state-of the-art quarters with the Center's vivarium.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-43
Application #
7671810
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-31
Project End
2012-12-31
Budget Start
2008-07-31
Budget End
2008-12-31
Support Year
43
Fiscal Year
2008
Total Cost
$136,415
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Antonescu, Cristina R; Agaram, Narasimhan P; Sung, Yun-Shao et al. (2018) A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions. Am J Surg Pathol 42:553-560
Baumann, Michael H; Majumdar, Susruta; Le Rouzic, Valerie et al. (2018) Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace. Neuropharmacology 134:101-107
Escalon, Joanna G; Harrington, Kate A; Plodkowski, Andrew J et al. (2018) Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated With Different Histologic Subtypes on Computed Tomography? J Comput Assist Tomogr 42:601-606
Rosen, Lauren E; Karrison, Theodore; Ananthanarayanan, Vijayalakshmi et al. (2018) Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study. Mod Pathol 31:598-606
Argani, Pedram; Pawel, Bruce; Szabo, Sara et al. (2018) Diffuse Strong BCOR Immunoreactivity Is a Sensitive and Specific Marker for Clear Cell Sarcoma of the Kidney (CCSK) in Pediatric Renal Neoplasia. Am J Surg Pathol 42:1128-1131
Lambertini, Matteo; Campbell, Christine; Bines, José et al. (2018) Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients. J Natl Cancer Inst :
Intlekofer, Andrew M; Joffe, Erel; Batlevi, Connie L et al. (2018) Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. Blood Cancer J 8:60
Wang, Hongmei; Deng, Jikui; Tang, Yi-Wei (2018) Profile of the Alere i Influenza A & B assay: a pioneering molecular point-of-care test. Expert Rev Mol Diagn 18:403-409
Tseng, Jill H; Aloisi, Alessia; Sonoda, Yukio et al. (2018) Long-Term Oncologic Outcomes of Uterine-Preserving Surgery in Young Women With Stage Ib1 Cervical Cancer. Int J Gynecol Cancer 28:1350-1359
Pronier, Elodie; Bowman, Robert L; Ahn, Jihae et al. (2018) Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis. Blood 132:1265-1278

Showing the most recent 10 out of 8799 publications